Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP840149.RAg16do-9awSrcbNysoGxpjid0NrBOtagUr4rNS-RIquk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP840149.RAg16do-9awSrcbNysoGxpjid0NrBOtagUr4rNS-RIquk130_assertion type Assertion NP840149.RAg16do-9awSrcbNysoGxpjid0NrBOtagUr4rNS-RIquk130_head.
- NP840149.RAg16do-9awSrcbNysoGxpjid0NrBOtagUr4rNS-RIquk130_assertion wasGeneratedBy ECO_0000203 NP840149.RAg16do-9awSrcbNysoGxpjid0NrBOtagUr4rNS-RIquk130_provenance.
- NP840149.RAg16do-9awSrcbNysoGxpjid0NrBOtagUr4rNS-RIquk130_assertion wasDerivedFrom befree-2016 NP840149.RAg16do-9awSrcbNysoGxpjid0NrBOtagUr4rNS-RIquk130_provenance.
- NP840149.RAg16do-9awSrcbNysoGxpjid0NrBOtagUr4rNS-RIquk130_assertion SIO_000772 20852404 NP840149.RAg16do-9awSrcbNysoGxpjid0NrBOtagUr4rNS-RIquk130_provenance.
- NP840149.RAg16do-9awSrcbNysoGxpjid0NrBOtagUr4rNS-RIquk130_assertion evidence source_evidence_literature NP840149.RAg16do-9awSrcbNysoGxpjid0NrBOtagUr4rNS-RIquk130_provenance.
- NP840149.RAg16do-9awSrcbNysoGxpjid0NrBOtagUr4rNS-RIquk130_assertion description "[MMP1 2G carriage (P = 0.0008), TIMP4 lower serum levels (P = 0.02), treatment with stavudine (P < 0.0001), treatment with zidovudine (P = 0.006) and absence of hepatitis C virus coinfection (P = 0.002) were associated with lipodystrophic syndrome by logistic regression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP840149.RAg16do-9awSrcbNysoGxpjid0NrBOtagUr4rNS-RIquk130_provenance.